scispace - formally typeset
W

Wei Mao

Researcher at Guangzhou University of Chinese Medicine

Publications -  23
Citations -  273

Wei Mao is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Kidney disease & Tripterygium. The author has an hindex of 8, co-authored 23 publications receiving 157 citations.

Papers
More filters
Journal ArticleDOI

Astragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: An updated systematic review and meta-analysis.

TL;DR: The low quality of evidence suggested that adjunctive use of A. membranaceus preparations in addition to conventional therapies may be effective and tolerated for short-term reduction of albuminuria, proteinuria, and serum creatinine in DKD patients.
Journal ArticleDOI

Chinese herbal medicine for diabetic kidney disease: a systematic review and meta-analysis of randomised placebo-controlled trials.

TL;DR: Based on moderate to low quality evidence, CHM may have beneficial effects on renal function and albuminuria beyond that afforded by conventional treatment in adults with DKD.
Journal ArticleDOI

Traditional Medicines and Kidney Disease in Low- and Middle-Income Countries: Opportunities and Challenges.

TL;DR: In the context of kidney diseases, the challenges and opportunities presented by traditional medicine practices are among the most important considerations for developing effective and sustainable public health strategies, especially concerning benefits and harms as mentioned in this paper.
Journal ArticleDOI

Ginkgo biloba Extract for Patients with Early Diabetic Nephropathy: A Systematic Review.

TL;DR: Ginkgo biloba extract is a valuable drug which has prospect in treating early diabetic nephropathy, especially with high UAER baseline level, and the safety for early diabetic nephropathy is uncertain.
Journal ArticleDOI

Sanqi oral solution ameliorates renal damage and restores podocyte injury in experimental membranous nephropathy via suppression of NFκB.

TL;DR: Results provide evidence that SQ exerts a novel therapeutic effect on MN via reducing proteinuria, ameliorating renal damage and restoring podocyte injuries, which are associated with the suppression of NFκB.